Search clinical trials for: Relapsed or relapse/refractory Multiple Myeloma
Total 213308 results
-
CelgeneCompletedMultiple MyelomaUnited States
-
Qilu Pharmaceutical Co., Ltd.Active, not recruitingMultiple Myeloma | Recurrent or RefractoryChina
-
AbbVieSumitomo Pharma Oncology, Inc.CompletedAcute Myeloid Leukemia (AML)United States, Germany, United Kingdom
-
CelgeneCompletedMultiple MyelomaNetherlands, Spain, Belgium, Austria, Switzerland, Italy, Germany, France, Ireland, United Kingdom, Denmark, Finland, Portugal, Turkey, Poland, Estonia, Greece, Norway, Slovakia, Sweden
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States, Canada
-
University of Illinois at ChicagoCompletedMultiple Myeloma, Relapsed | Multiple Myeloma, Refractory to Standard TreatmentUnited States
-
MorphoSys AGCompletedMultiple MyelomaAustria, Germany
-
AstraZenecaCompletedAcute Myeloid Leukemia | Multiple Myeloma | Chronic Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | High Risk Myelodysplastic Syndrome | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin Lymphoma | Richter's Syndrome | T-cell Non-Hodgkin Lymphoma | Relapsed or Refractory...United Kingdom, Germany, Netherlands
-
Janssen Scientific Affairs, LLCCompletedMultiple MyelomaUnited States
-
Merck Sharp & Dohme LLCTerminated
-
Dana-Farber Cancer InstituteNovartisCompletedMultiple Myeloma in RelapseUnited States
-
CelgeneCompletedMultiple MyelomaAustria, Italy, France, Spain, Netherlands, Germany, Greece, United Kingdom
-
Gilead SciencesTerminatedMultiple MyelomaUnited States
-
CelgeneCompleted
-
Novartis PharmaceuticalsCompletedMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaItaly, Australia, Germany, Spain, France, Japan, United States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, France
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Japan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Multiple Myeloma-Light Chain OnlyUnited States
-
Bristol-Myers SquibbCompleted
-
AbbVieCelgeneTerminatedMultiple MyelomaUnited States, Spain, United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Recurrent Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Plasma Cell Myeloma | Myeloproliferative Neoplasm | Recurrent... and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterCelgeneCompletedRecurrent Plasma Cell MyelomaUnited States
-
AmgenTerminated
-
Merck Sharp & Dohme LLCCompleted
-
Chinook Therapeutics, Inc.TerminatedMultiple MyelomaUnited States
-
Oncopeptides ABApproved for marketingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Sun Yat-sen UniversityUnknownRelapsed, Refractory, Multiple MyelomaChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedFatigue | Anemia | Weight Loss | Thrombocytopenia | Fever | Refractory Plasma Cell Myeloma | Lymphadenopathy | Refractory Chronic Lymphocytic Leukemia | Recurrent Plasma Cell Myeloma | Splenomegaly | Recurrent Chronic Lymphocytic Leukemia | Lymphocytosis | Night SweatsUnited States
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
AmgenTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaUnited States, Turkey, Canada, Netherlands, Australia, Germany, France
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Novartis PharmaceuticalsCompletedMultiple MyelomaUnited States, Germany, Spain, Singapore
-
Novartis PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Karyopharm Therapeutics IncCompletedMultiple Myeloma | Relapsed and/or Refractory Multiple MyelomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedRecurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
The Sixth Affiliated Hospital of Wenzhou Medical...Zhejiang Qixin BiotechUnknown
-
Merck Sharp & Dohme LLCCompletedRelapsed or Refractory Multiple Myeloma
-
Janssen Research & Development, LLCCompleted
-
Case Comprehensive Cancer CenterCompletedRefractory Multiple MyelomaUnited States
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
Universitaire Ziekenhuizen KU LeuvenWithdrawnHematologic Diseases | Multiple MyelomaBelgium
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Oncopeptides ABTerminatedRelapsed and/or Relapsed-refractory Multiple MyelomaUnited States, Netherlands, Denmark, Sweden, Italy
-
Parameswaran HariCompletedMultiple MyelomaUnited States
-
PfizerCompletedMultiple Myeloma | Plasma Cell LeukemiaUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...CARsgen Therapeutics Co., Ltd.Active, not recruitingRefractory or Relapsed Multiple MyelomaChina
-
First Affiliated Hospital of Zhejiang UniversityCARsgen Therapeutics Co., Ltd.Active, not recruitingRefractory or Relapsed Multiple MyelomaChina
-
Array Biopharma, now a wholly owned subsidiary...CompletedMultiple Myeloma, Plasma Cell LeukemiaUnited States